Scolaris Content Display Scolaris Content Display

Anestesia local paracervical para la dilatación cervical y la intervención uterina

Contraer todo Desplegar todo

Resumen

disponible en

Antecedentes

La dilatación cervical y la intervención uterina se pueden realizar bajo sedación, anestesia local o general en afecciones obstétricas y ginecológicas. Muchos ginecólogos utilizan la anestesia local paracervical aunque su efectividad es incierta. Esta revisión fue publicada originalmente en 2009 y se actualizó en 2013.

Objetivos

Los objetivos de esta revisión eran determinar la efectividad y la seguridad de la anestesia local paracervical para la dilatación cervical y la intervención uterina versus ningún tratamiento, placebo, otros métodos de anestesia regional, sedación y analgesia sistémica y anestesia general.

Métodos de búsqueda

La búsqueda se volvió a ejecutar en agosto de 2013. Se hicieron búsquedas en el Registro Cochrane Central de Ensayos Controlados (Cochrane Central Register of Controlled Trials) (CENTRAL) (The Cochrane Library 2013, número 8), MEDLINE (1966 hasta agosto de 2013), EMBASE (1980 hasta agosto de 2013), y en listas de referencias de artículos. La búsqueda original se realizó en enero de 2006.

Criterios de selección

Se incluyeron estudios clínicos aleatorios o controlados que reclutaron pacientes a las que se les realizó dilatación cervical e intervención uterina por afecciones obstétricas y ginecológicas. Se incluyeron los estudios que compararon anestesia paracervical con ningún tratamiento, placebo, otros métodos de anestesia regional, sedación sistémica y analgesia, o anestesia general.

Obtención y análisis de los datos

Dos revisores, de forma independiente, evaluaron los estudios, extrajeron los datos y los verificaron e introdujeron en Review Manager.

Resultados principales

Esta revisión actualizada incluye nueve nuevos estudios, con un total de 26 estudios con 28 comparaciones que implican a 2790 participantes. Ningún estudio de anestesia local paracervical versus anestesia general cumplió los criterios. Diez estudios compararon anestésico local versus placebo. El anestésico local paracervical (ALP) redujo el dolor en la dilatación cervical con una diferencia de medias estandarizada (DME) de 0,37 (IC del 95%: 0,17 a 0,58) y un riesgo relativo (RR) de dolor intenso de 0,16 (IC del 95%: 0,06 a 0,74). El ALP también redujo el dolor abdominal durante, pero no después de, la intervención uterina (DME 0,74; IC del 95%: 0,28 a 1,19); no hubo pruebas de cualquier efecto sobre el dolor posoperatorio lumbar o del hombro. Las comparaciones contra ningún tratamiento no demostraron cualquier efecto del ALP. Cinco estudios compararon bloqueo paracervical con bloqueo uterosacro, bloqueo intracervical, o anestesia intrauterina tópica. Dos de tres estudios no mostraron diferencias significativas en el dolor durante el procedimiento. Comparada con la instilación intrauterina, el ALP redujo levemente el dolor intenso (de 8,3 a 7,6; en una escala de 10 puntos), que puede ser insignificante. Seis estudios compararon ALP con sedación. No hubo diferencias estadísticamente significativas en el dolor durante o después del procedimiento, la necesidad de analgesia posoperatoria, los efectos adversos, la satisfacción de la paciente y la percepción del operador de la analgesia. Para la evaluación del riesgo de sesgo se utilizaron seis dominios y se encontró que más de la mitad de los estudios incluidos tuvo bajo riesgo de sesgo.

Conclusiones de los autores

Ninguna técnica proporcionó un control del dolor confiable en los 26 estudios incluidos. Algunos estudios informaron que las pacientes presentaron dolor intenso (puntuaciones medias de 7 a 9 de 10) durante la intervención uterina, independientemente de la técnica analgésica utilizada. Se concluyó que las pruebas disponibles no logran mostrar si el bloqueo paracervical es inferior, equivalente o superior a las técnicas analgésicas alternativas en cuanto a la eficacia y la seguridad, para las pacientes a las que se les realizan intervenciones uterinas. Se indica que es probable que la paciente considere que las calificaciones y la gravedad del dolor durante las intervenciones uterinas, cuando se realizan estando despierta, son inadmisibles cuando no hay bloqueo neuroaxial, el cual no es modificado por el bloqueo paracervical.

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.

Resumen en términos sencillos

disponible en

Anestesia local paracervical para la dilatación cervical y las intervenciones uterinas

El bloqueo paracervical incluye la inyección de un anestésico local alrededor del cuello uterino para adormecer los nervios cercanos. La dilatación cervical y las intervenciones uterinas (como histeroscopias, biopsias del endometrio, legrado fraccionado y abortos provocados por aspiración) se pueden realizar sin analgesia ni anestesia; con inyecciones regionales de anestésicos o con un bloqueo paracervical; el uso de analgésicos orales o intravenosos y sedantes; o bajo anestesia general. Muchos ginecólogos usan el bloqueo paracervical para la intervención uterina, pero no está claro cuán eficaz y seguro es este método. Se incluyeron nueve estudios nuevos en esta revisión actualizada, con un total de 26 estudios que incluyeron 2790 mujeres a las que se les realizaron intervenciones uterinas. Las pacientes fueron asignadas al azar a bloqueo paracervical o una alternativa. Se encontró que, estadísticamente, las pacientes tuvieron significativamente menos dolor durante la dilatación cervical y la intervención uterina con bloqueo paracervical que con inyección placebo (solución salina o agua) pero es posible que esta diferencia no sea clínicamente importante. El bloqueo paracervical no tuvo efectos en cinco estudios no controlados. No hubo pruebas de que el bloqueo paracervical alivió el dolor en comparación con métodos anestésicos regionales alternativos o analgésicos sistémicos y sedantes. Hubo muy poca información sobre efectos secundarios importantes. Después de la actualización esta revisión encontró que ninguna técnica anestésica local previno el dolor de forma tan efectiva como se esperaría de la anestesia general.

Authors' conclusions

Implications for practice

All of the techniques used in the 26 included studies failed to reliably prevent pain in conscious women having uterine interventions. The available evidence does not show if paracervical block is inferior, equivalent, or superior to the alternative analgesic techniques, either in terms of efficacy or safety. Some women are likely to experience severe pain if they undergo uterine interventions with paracervical blockade, or one of the other conscious methods assessed in this review. Either general anaesthesia or neuraxial blockade is probably necessary to avoid severe pain during uterine intervention. Clinicians should stop using paracervical block as a method of pain control.

Implications for research

Our systematic review showed that pain experienced by women having uterine interventions is inadequately controlled by paracervical block. The findings of the 26 included studies suggest that the other methods that were compared with paracervical block (local anaesthetic methods, sedation and systemic analgesics) also inadequately control the pain. Researchers should conduct systematic reviews of these other methods to confirm or refute this finding. Should they do so, potential participants in trials should be informed of the results of this systematic review, which should also inform the design of any future randomized controlled trials.

Summary of findings

Open in table viewer
Summary of findings for the main comparison. Paracervical versus placebo for cervical dilatation and uterine intervention

Paracervical versus placebo for cervical dilation and uterine intervention

Patient or population: patients with cervical dilatation and uterine intervention
Settings:
Intervention: paracervical versus placebo

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of Participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Control

Paracervical versus placebo

Pain dilating cervix

The mean pain dilating cervix in the intervention groups was
0.37 standard deviations lower
(0.58 to 0.17 lower)

381
(4 studies)

⊕⊕⊕⊕
high

SMD ‐0.37 (‐0.58 to ‐0.17)

Pain during uterine intervention ‐ Risk of any pain

Study population

RR 0.85
(0.54 to 1.34)

242
(2 studies)

⊕⊕⊝⊝
low1

926 per 1000

787 per 1000
(500 to 1000)

Moderate

910 per 1000

773 per 1000
(491 to 1000)

Pain during uterine intervention ‐ Risk of severe pain

Study population

RR 0.16
(0.04 to 0.74)

242
(2 studies)

⊕⊕⊕⊝
moderate2

149 per 1000

24 per 1000
(6 to 110)

Moderate

156 per 1000

25 per 1000
(6 to 115)

Postoperative pain ‐ Immediately after the procedure

The mean postoperative pain ‐ immediately after the procedure in the intervention groups was
0.34 standard deviations lower
(0.92 lower to 0.24 higher)

223
(3 studies)

⊕⊕⊝⊝
low

SMD ‐0.34 (‐0.92 to 0.24)

Adverse effects ‐ Nausea and vomiting

Study population

RR 0.24
(0.02 to 2.8)

429
(3 studies)

⊕⊕⊕⊝
moderate

265 per 1000

64 per 1000
(5 to 742)

Moderate

250 per 1000

60 per 1000
(5 to 700)

Adverse effects ‐ Sweating

Study population

RR 1.08
(0.7 to 1.67)

142
(1 study)

⊕⊕⊕⊝
moderate

352 per 1000

380 per 1000
(246 to 588)

Moderate

352 per 1000

380 per 1000
(246 to 588)

Adverse effects ‐ Hypotension

Study population

RR 3.06
(1.21 to 7.78)

171
(2 studies)

⊕⊕⊕⊝
moderate

58 per 1000

178 per 1000
(70 to 452)

Moderate

50 per 1000

153 per 1000
(61 to 389)

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 Heterogeneity between studies may arise from differences in outcomes
2 Limitation of design: lack of allocation concealment

Open in table viewer
Summary of findings 2. Paracervical versus no anaesthesia for cervical dilatation and uterine intervention

Paracervical versus no anaesthesia for cervical dilatation and uterine intervention

Patient or population: patients with cervical dilatation and uterine intervention
Settings:
Intervention: paracervical versus no anaesthesia

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of Participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Control

Paracervical versus no anaesthesia

Pain during the procedure

Study population

OR 0.99
(0.52 to 1.86)

215
(1 study)

⊕⊕⊕⊕
high

769 per 1000

767 per 1000
(633 to 861)

Moderate

769 per 1000

767 per 1000
(634 to 861)

Postoperative pain at different times ‐ Immediately after the procedure

The mean postoperative pain at different times ‐ immediately after the procedure in the intervention groups was
0.46 lower
(1.22 lower to 0.3 higher)

273
(2 studies)

⊕⊕⊕⊕
high

Postoperative pain at different times ‐ 5 minutes after the procedure

The mean postoperative pain at different times ‐ 5 minutes after the procedure in the intervention groups was
0.46 lower
(1.41 lower to 0.49 higher)

58
(1)

See comment

Postoperative pain at different times ‐ 10 minutes after the procedure

The mean postoperative pain at different times ‐ 10 minutes after the procedure in the intervention groups was
0.04 lower
(0.69 lower to 0.61 higher)

58
(1 study)

See comment

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; OR: Odds ratio

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

Open in table viewer
Summary of findings 3. Paracervical block versus other regional anaesthesia for cervical dilatation and uterine intervention

Paracervical block versus other regional anaesthesia for cervical dilatation and uterine intervention

Patient or population: patients with cervical dilatation and uterine intervention
Settings:
Intervention: paracervical block versus other regional anaesthesia

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of Participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Control

Paracervical block versus other regional anaesthesia

Pain during the procedure

Study population

OR 1.41
(0.68 to 2.91)

120
(1 study)

⊕⊕⊕⊝
moderate1

383 per 1000

467 per 1000
(297 to 644)

Moderate

383 per 1000

467 per 1000
(297 to 644)

Pain during cervical dilatation

The mean pain during cervical dilatation in the intervention groups was
0.52 lower
(1.28 lower to 0.24 higher)

163
(2 studies)

⊕⊕⊝⊝
low2

Pain during uterine intervention: continuous

See comment

See comment

Not estimable

271
(3 studies)

⊕⊝⊝⊝
very low3,4

Postoperative pain at different time: continuous

See comment

See comment

Not estimable

307
(2 studies)

⊕⊕⊕⊕
high

Adverse effects

See comment

See comment

Not estimable

55
(1 study)

⊕⊕⊝⊝
low5

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; OR: Odds ratio

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 Limitation of study: lack of allocation concealment, blinding
2 Heterogeneity between studies may arise from differences of populations
3 Heterogeneity between studies may arise from difference of outcomes
4 Imprecision: the study had wide confidence intervals around the estimate of the effect
5 Limitation of study: lack of blinding

Open in table viewer
Summary of findings 4. Paracervical versus systemic analgesia for cervical dilatation and uterine intervention

Paracervical versus systemic analgesia for cervical dilatation and uterine intervention

Patient or population: patients with cervical dilatation and uterine intervention
Settings:
Intervention: paracervical versus systemic analgesia

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of Participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Control

Paracervical versus systemic analgesia

Pain during uterine intervention

See comment

See comment

Not estimable

402
(3 studies)

⊕⊕⊝⊝
low1

Postoperative pain

See comment

See comment

Not estimable

984
(2 studies)

⊕⊕⊕⊕
high

Requirement for postoperative analgesics

See comment

See comment

Not estimable

166
(1 study)

⊕⊕⊝⊝
low

Adverse effects

See comment

See comment

Not estimable

571
(3 studies)

⊕⊕⊝⊝
low

Patient satisfaction

Study population

Not estimable

166
(1 study)

⊕⊕⊝⊝
low

940 per 1000

0 per 1000
(0 to 0)

Moderate

941 per 1000

0 per 1000
(0 to 0)

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 Limitation of studies: lack of allocation concealment, blinding

Background

Description of the condition

Indications for cervical dilatation and uterine intervention include abnormal uterine bleeding that does not respond to medical treatment, postmenopausal bleeding, and abortion. General anaesthesia provides adequate operating conditions for cervical dilatation and uterine intervention. However, there are some situations where general anaesthesia is hazardous, for example when patients are frail, unwell, or when no anaesthesiologist is available. The choice of anaesthesia and analgesia is dependent on effectiveness, cost, safety, and side effects. Other factors are the patient's and physician's preferences. Paracervical local anaesthesia offers an alternative for cervical dilatation and uterine intervention as it does not require general anaesthetic equipment or personnel trained to give general anaesthesia.

Description of the intervention

Paracervical block has been performed since 1925 (Aimakhu 1972). Injection of local anaesthetic around the cervix, at the 'three and nine o'clock positions', anaesthetizes the second to fourth sacral nerve roots as they pass through Frankenhäuser's plexus at a depth of 2 to 4 mm (Piyamongkol 1998). Physical pain originates from the S2 to S4 parasympathetic fibres (the Frankenhäuser plexus) that innervate the cervix and the lower part of the uterine body (Scott 1976; Smith 1991). The uterine fundus and lower part of the uterine body are innervated by sympathetic fibres from T10 to L1 via the inferior hypogastric nerve and the ovarian plexus (Maltzer 1999).

How the intervention might work

Most gynaecologic procedures cause pain or discomfort, especially on cervical dilatation. The pain is transmitted by sensory and sympathetic pathways to the lateral spinothalamic tracts of the spinal cord. Paracervical anaesthetics block transmission of pain through sympathetic, parasympathetic and sensory fibres before they enter the uterus at the level of the internal os (Chanrachakul 2001).

Why it is important to do this review

Many gynaecologists inject paracervical local anaesthetic before cervical dilatation and uterine intervention, but its effectiveness is unclear. The effectiveness of paracervical blockade may be affected by the anatomical and physiological changes that accompany pregnancy and the menopause. We compared the effectiveness and safety of paracervical blockade before cervical dilatation and uterine interventions versus no treatment, placebo, other methods of regional anaesthesia, sedation and systemic analgesia, and general anaesthesia.

Objectives

The objectives of this review were to determine the effectiveness and safety of paracervical local anaesthesia for cervical dilatation and uterine intervention, versus no treatment, placebo, other methods of regional anaesthesia, sedation and systemic analgesia, and general anaesthesia.

Methods

Criteria for considering studies for this review

Types of studies

We included randomized controlled trials (RCTs) in which allocation was either randomized or pseudo‐randomized (alternate days, weeks, odd and even hospital numbers). We excluded concurrent cohort and observational studies.

Types of participants

We included women of any age who underwent cervical dilatation and uterine intervention for any indication.

Types of interventions

We included studies in which at least one group had paracervical block. The comparison interventions were: placebo; no treatment; other regional anaesthesia; sedation and systemic analgesia. We did not compare one type of local anaesthetic with another.

We anticipated that we would conduct meta‐analyses for the following comparisons.

  1. Paracervical local anaesthesia versus placebo.

  2. Paracervical local anaesthesia versus no anaesthesia.

  3. Paracervical local anaesthesia versus other methods of regional anaesthesia.

  4. Paracervical local anaesthesia versus systemic analgesia.

  5. Paracervical local anaesthesia versus general anaesthesia.

Types of outcome measures

We included pain, adverse effects, and patient satisfaction.

Primary outcomes

  1. Pain during or after cervical dilatation and uterine intervention, measured as categorical or continuous data (for example on a visual analogue scale)

  2. Adverse effects (such as nausea, vomiting, hypotension)

  3. The requirement of additional analgesia

Secondary outcomes

  1. Patient satisfaction (as defined by the study authors)

Search methods for identification of studies

Electronic searches

We reran our search to August 2013. We searched the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library (2013, Issue 8) (Appendix 1), MEDLINE via OvidSP (1966 to August 2013) (Appendix 2), EMBASE via OvidSP (January 1980 to August 2013) (Appendix 3), and reference lists of articles. Our original search was performed in January 2006.

We combined our search strategies with the Cochrane highly sensitive search strategy for RCTs as contained in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011).

We searched for ongoing and recently published studies in www.controlled‐studies.com. We did not apply any language restrictions.

Searching other resources

We handsearched the reference lists of reviews, randomized and non‐randomized studies, and editorials for additional studies. We contacted the main authors of studies and experts in this field to ask for any missed, unreported, or ongoing studies.

Data collection and analysis

Selection of studies

We did not blind the names of the study authors, institutions, or journals of publication. Two authors (TT and US) independently evaluated the eligibility of studies from their title, abstract, and the full paper. We analysed the results of the randomized controlled studies that we had selected and graded their methodological quality by using the GradeProfiler programme version 3.2.2 and through construction of the risk of bias tables for the following items: random sequence generation; allocation concealment; blinding of the intervention administered; incomplete data; selective reporting; and other bias. We used the GradeProfiler programme version 3.2.2 to grade the quality of the relevant articles in terms of their: limitation of design; inconsistency; indirectness; imprecision; and publication bias. The quality of evidence across studies for the outcome was graded into four levels: high; moderate; low; and very low. We resolved any disagreements through discussion. The third author (PL) evaluated disputed studies to obtain a consensus.

Data extraction and management

We used the standard methods of the Cochrane Anaesthesia Review Group. Two authors (TT and US) scrutinized all the titles and abstracts for their suitability and independently extracted data. One author (TT) checked the data and entered them into RevMan 5.1. We contacted the authors of any study that had missing data.

Assessment of risk of bias in included studies

We evaluated the validity and design characteristics of each trial. We assessed: random sequence generation, allocation concealment, blinding, incomplete data, selective reporting, and other bias. We performed summary assessments of the risk of bias for each important outcome (across domains) within and across studies. We applied a 'Risk of bias' graph and a 'Risk of bias' summary figure (Higgins 2011) (Figure 1, Figure 2). We planned to include high and low risk studies, and to present multiple analyses.


Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.


Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

Unit of analysis issues

The unit of analysis was the individual participant. In this review we included only parallel group trials, with only one measurement per participant.

Dealing with missing data

We contacted Chanrachakul 2001 in order to retrieve the relevant data but the data were unavailable. We chose to explore selective outcome reporting by comparing publications with their protocols, if the latter were available.

Assessment of heterogeneity

When we suspected important heterogeneity, determined by an I2 statistic greater than 50% (Higgins 2003), we investigated differences in clinical factors between studies. When meta‐analysis was inappropriate, we drew conclusions from the descriptive elements of the studies; methodological quality; number of studies with consistent findings; plausibility of the results; and the strength of the associations in the primary studies as well as consensus among authors.

Assessment of reporting biases

We planned to explore whether the included articles had any reporting biases, both publication and funding biases.

Data synthesis

Where appropriate, we analysed pooled data using RevMan 5.1. The method of meta‐analysis was dependent on the nature of the outcomes. For categorical data (for example the proportion of participants with an event) we related the number reporting an event to the number at risk in each group to derive a relative risk (RR) and 95% confidence interval (CI). We pooled continuous differences between groups in the meta‐analysis (for example pain relief on a visual analogue scale (VAS)) as mean differences (MD) or standardized mean differences (SMD), as appropriate, with their 95% CIs. In the case of various units of pain score measurements among studies, we used SMD for analysis. We used a fixed‐effect model unless significant heterogeneity was encountered, in which case we used a random‐effects model.

Subgroup analysis and investigation of heterogeneity

We considered subgroup analyses based on:

  • patients' characteristics e.g. menopausal status (before versus after), parity (zero versus the rest);

  • types of diseases;

  • nature, dose, and duration of interventions.

We did not perform any subgroup and sensitivity analyses because of the small number of included studies; and no data were available on potential factors for subgroup analysis.

Sensitivity analysis

We planned the following sensitivity analyses: quality of allocation concealment (adequate, unclear, or inadequate); blinding outcome assessment (adequate, unclear, or inadequate or not performed); and rates of withdrawals for each outcome.

Results

Description of studies

Results of the search

We identified 1218 studies of which 96 had relevant titles and abstracts. We excluded 10 of these studies (Agostini 2008; Allen 2006; Allen 2009; Cansino 2009; Habersetzer 1972; Harper 1997; Karasahin 2011; Manyou 2008; Naki 2011; Phittayawechwiwat 2007) (see Characteristics of excluded studies). We excluded 70 studies in total (Figure 3). We found no ongoing trials. Titles and abstracts were unclear in three studies (Chaudhuri 1980; Regina 1987; Sen 1980) and we put them into 'Studies awaiting classification'. We identified 26 relevant studies with 28 comparisons as Kan 2004 and Sharma 2009 studied more than two groups (see Characteristics of included studies), involving a total of 2790 women, that were published in full. Our full search results are in Figure 3.


Searching results

Searching results

Included studies

In our original review we included 17 studies. In this updated review we included nine new studies (Al‐Sunaidi 2007; Amirian 2009; Chudnoff 2010; Lazenby 2009; Lopez 2007; Mankowski 2009; Renner 2012; Sharma 2009; Thongrong 2011) making a total of 26 studies. Two of the new studies compared paracervical block versus placebo (Amirian 2009; Chudnoff 2010) making a total of 10 studies. We included three additional studies (Lopez 2007; Sharma 2009; Thongrong 2011) of paracervical block versus sedation and systemic analgesia; two additional studies (Al‐Sunaidi 2007; Mankowski 2009) versus other regional techniques; and one additional study versus no treatment (Renner 2012). We did not find any studies of paracervical block versus general anaesthesia.

Excluded studies

In our original review, we excluded 80 studies.

In our updated review we excluded an additional 10 newly identified studies (Agostini 2008; Allen 2006; Allen 2009; Cansino 2009; Habersetzer 1972; Harper 1997; Karasahin 2011; Manyou 2008; Naki 2011; Phittayawechwiwat 2007). We then re‐evaluated the studies we had excluded in our previous review. We removed 18 studies from the list of excluded studies as they were not RCTs (Amyot‐Legault 1981; Coker 1968; Fernandez 1997; Ferry 1994; Formiga‐Filho 1974; Gad 1967; Lewis 1971; Littlepage 1969; Readman 2004; Reguer Noriega 1973; Rotchell 1976; Sandmire 1974; Santonja 1974; Strausz 1971; Thonneau 1998; Toth 2000; Van Praagh 1967; Walden 1973).

Studies awaiting classification

Three studies remain unavailable to us in full text (Chaudhuri 1980; Regina 1987; Sen 1980).

Risk of bias in included studies

Please see the table Characteristics of included studies for the detailed descriptions of bias. The domains of bias are presented in the 'Risk of bias' graph and 'Risk of bias' summary figures (Figure 1, Figure 2).

Allocation

We judged 17 studies to have a low risk of bias for random sequence generation (Al‐Sunaidi 2007; Amirian 2009; Carroll 2005; Chanrachakul 2001; Chudnoff 2010; Cicinelli 1998; Egziabher 2002; Glantz 2001; Gómez 2004; Guida 2003; Kan 2004; Lau 1999; Lopez 2007; Mankowski 2009; Renner 2012; Sharma 2009; Vercellini 1994). There was an unclear risk of bias in seven studies (Buppasiri 2005; Chatfield 1970; Lazenby 2009; Miller 1996; Mola 1996; Titapant 2003; Yazaci 2003), and a high risk of bias in two studies (Finikiotis 1992; Thongrong 2011). We judged allocation concealment to be low risk of bias in 14 studies (Amirian 2009; Carroll 2005; Chanrachakul 2001; Chudnoff 2010; Cicinelli 1998; Glantz 2001; Gómez 2004; Kan 2004; Lau 1999; Lazenby 2009; Lopez 2007; Mankowski 2009; Mola 1996; Renner 2012), unclear in six studies (Buppasiri 2005; Egziabher 2002; Guida 2003; Miller 1996; Titapant 2003; Yazaci 2003), and at a high risk of bias in six studies (Al‐Sunaidi 2007; Chatfield 1970; Finikiotis 1992; Sharma 2009; Thongrong 2011; Vercellini 1994).

Blinding

Of the 26 studies, 15 adequately blinded women to their allocated intervention (Amirian 2009; Chanrachakul 2001; Chatfield 1970; Chudnoff 2010; Cicinelli 1998; Egziabher 2002; Glantz 2001; Gómez 2004; Kan 2004; Lau 1999; Lazenby 2009; Mankowski 2009; Miller 1996; Renner 2012; Titapant 2003). Nine studies adequately blinded treatment providers to the allocated intervention (Amirian 2009; Chanrachakul 2001; Chatfield 1970; Cicinelli 1998; Egziabher 2002; Glantz 2001; Lau 1999; Miller 1996; Titapant 2003). Thirteen studies adequately blinded outcome assessors to the allocated intervention (Amirian 2009; Chanrachakul 2001; Chatfield 1970; Chudnoff 2010; Cicinelli 1998; Egziabher 2002; Glantz 2001; Gómez 2004; Kan 2004; Lau 1999; Miller 1996; Renner 2012; Titapant 2003). Three of these studies (Chatfield 1970; Cicinelli 1998; Glantz 2001) blinded assessors to outcomes other than abdominal pain.

Incomplete outcome data

All studies completed follow up for all women. Seven studies were at high risk of incomplete outcome data (Al‐Sunaidi 2007; Amirian 2009; Buppasiri 2005; Chanrachakul 2001; Chatfield 1970; Chudnoff 2010; Cicinelli 1998; Kan 2004; Lau 1999; Lazenby 2009); risk of attrition bias was unclear in two (Finikiotis 1992; Mola 1996), and low in 17 studies (Carroll 2005; Egziabher 2002; Glantz 2001; Guida 2003; Gómez 2004; Kan 2004; Lau 1999; Lazenby 2009; Lopez 2007; Mankowski 2009; Miller 1996; Renner 2012; Sharma 2009; Thongrong 2011; Titapant 2003; Vercellini 1994; Yazaci 2003).

Selective reporting

Of the 26 studies, 24 were free of selective reporting (Al‐Sunaidi 2007; Amirian 2009; Buppasiri 2005; Chanrachakul 2001; Chatfield 1970; Chudnoff 2010; Cicinelli 1998; Egziabher 2002; Finikiotis 1992; Glantz 2001; Gómez 2004; Guida 2003; Kan 2004; Lau 1999; Lazenby 2009; Lopez 2007; Mankowski 2009; Miller 1996; Mola 1996; Sharma 2009; Thongrong 2011; Titapant 2003; Vercellini 1994; Yazaci 2003), one was unclear (Carroll 2005), and one was at high risk (Renner 2012) (see Figure 1, Figure 2).

Other potential sources of bias

Two studies (Kan 2004; Lazenby 2009) presented the trust fund information. Sample size calculations were presented in 14 studies (Chanrachakul 2001; Chudnoff 2010; Cicinelli 1998; Egziabher 2002; Glantz 2001; Gómez 2004; Guida 2003; Kan 2004; Lau 1999; Lazenby 2009; Lopez 2007; Renner 2012; Thongrong 2011; Vercellini 1994). Amirian 2009 excluded the participants who had uterine perforation or severe bleeding during curettage after the allocation concealment was performed. We judged one study to be unclear of other potential biases (Al‐Sunaidi 2007).

Effects of interventions

See: Summary of findings for the main comparison Paracervical versus placebo for cervical dilatation and uterine intervention; Summary of findings 2 Paracervical versus no anaesthesia for cervical dilatation and uterine intervention; Summary of findings 3 Paracervical block versus other regional anaesthesia for cervical dilatation and uterine intervention; Summary of findings 4 Paracervical versus systemic analgesia for cervical dilatation and uterine intervention

Paracervical local anaesthesia versus placebo

(Analysis 1.1 to Analysis 1.9)
Ten studies compared paracervical block versus placebo (Amirian 2009; Chanrachakul 2001; Chatfield 1970; Chudnoff 2010; Cicinelli 1998; Egziabher 2002; Glantz 2001; Lau 1999; Miller 1996; Titapant 2003). Uterine interventions included hysteroscopy, endometrial biopsy, fractional curettage, and vacuum aspiration. The local anaesthetics used were lidocaine, chloroprocaine, and xylocaine (see Characteristics of included studies for details).

Pain during speculum insertion (Analysis 1.1)

There was no evidence of an effect of paracervical block, SMD 0.20 (95% CI ‐0.35 to 0.74).

Pain on tenaculum placement (Analysis 1.2)

There was no evidence of an effect of paracervical block, MD ‐0.70 (95% CI ‐2.26 to 0.86).

Pain dilating cervix (Analysis 1.3)

There was evidence that paracervical block reduced the pain of cervical dilatation, SMD ‐0.39 (95% CI ‐0.72 to ‐0.07).

Pain during uterine interventions (Analysis 1.4)

There was evidence that paracervical block reduced the pain of uterine interventions (carbon dioxide insufflation, endometrial biopsy, fractional curettage, suction evacuation, or aspiration), SMD ‐0.74 (95% CI ‐1.19 to ‐0.28). However, there was substantial heterogeneity across these subgroups (I2 = 85%, P < 0.0001). Within the subgroups there was evidence of an effect for endometrial biopsy and suction aspiration (SMD ‐1.71, 95% CI ‐2.26 to ‐1.17; and SMD ‐0.90, 95% CI ‐1.47 to ‐0.32 respectively).

Pain during uterine interventions (risk of pain) (Analysis 1.5, Analysis 1.6)

There was evidence that paracervical block reduced the risk of severe pain but not any pain (RR 0.16, 95% CI 0.04 to 0.74; RR 0.87, 95% CI 0.68 to 1.12 respectively). Chanrachakul 2001 reported that paracervical block significantly reduced the median pain score during fractional curettage, from 6.0 to 4.0 (statement unsupported by a P value). There was no evidence of an effect in a study of tubal insert placement (Chudnoff 2010) (see Additional Table 1, Appendix 4).

Open in table viewer
Table 1. Pain: paracervical local anaesthesia versus placebo, single study analyses

Outcome

Study

Participants

Statistical method

Effect estimate

Pain on intracervical injection

Chudnoff 2010

80

Mean Difference (IV, Fixed, 95%CI)

‐0.63 [‐1.33 to 0.07]

Postoperative pain (Analysis 1.7)

There was no evidence that paracervical block reliably reduced postoperative pain (see also Appendix 5, Appendix 6, Appendix 7).

Shoulder pain (Analysis 1.8)

There was no evidence that paracervical block reduced the risk of shoulder pain.

Adverse effects (Analysis 1.9)

Paracervical block did not change the risk of sweating, nausea or vomiting. In one study (Lau 1999) the risk of hypotension after paracervical block was greater than after placebo injection, RR 3.06 (95% CI 1.21 to 7.78). In Miller 1996 3/27 women developed symptoms consistent with lidocaine toxicity (tingling lips, dizziness).

Additional drug requirement

There was no evidence that paracervical block reduced the need for additional drugs, including general anaesthesia (Amirian 2009) (see Appendix 8, Appendix 9).

Paracervical local anaesthesia versus no anaesthesia

(Analysis 2.1)

Six studies compared paracervical block versus no treatment (Carroll 2005; Gómez 2004; Kan 2004; Lazenby 2009; Renner 2012; Vercellini 1994). In two studies women had a hysteroscopy (Carroll 2005; Vercellini 1994) and in four studies women had suction termination or evacuation of incomplete miscarriages (Gómez 2004; Kan 2004; Lazenby 2009; Renner 2012).

Pain during the procedure

Meta‐analysis was not performed for this outcome. Kan 2004 and Lazenby 2009 found no evidence that paracervical block reduced median pain scores during or after suction termination under sedation when compared to no block. Gómez 2004 reported no difference in intraoperative pain as recalled 10 minutes after the procedure (Appendix 10). There was no evidence for significant differences in pain during hysteroscopy and endometrial biopsy in Vercellini 1994 (Additional Table 2), but Renner 2012 reported different results on pain reduction (Additional Table 2). This study found that baseline pain and pain on speculum insertion were not significantly different between paracervical local anaesthesia and no treatment (Appendix 11, Appendix 12). Pain during paracervical injection was greater in the paracervical local anaesthesia group (Appendix 13) but pain on cervical dilation and aspiration was significantly lower with paracervical local anaesthesia than with no treatment (Appendix 14, Appendix 15).

Open in table viewer
Table 2. Pain during uterine intervention: paracervical local anaesthesia versus no anaesthesia, single study analyses

Outcomes

Study

Participants

Statistical method

Effect estimate

Hysteroscopy

Vercellini 1994

177

Mean Difference (IV, Random, 95%CI)

‐0.40 [‐1.02 to 0.22]

Endometrial biopsy

Vercellini 1994

177

Mean Difference (IV, Random, 95%CI)

‐0.50 [‐1.16 to 0.16]

Aspiration

Renner 2012

120

Mean Difference (IV, Fixed, 95% CI)

‐26.00 [‐33.48, ‐18.52]

Postoperative pain (Analysis 2.1)

There was no evidence that paracervical block reduced postoperative pain (also see Appendix 16).

Adverse effects

No study found evidence for differences in the risks of adverse effects.

Patient satisfaction

Kan 2004 did not find evidence for differences in patient satisfaction. Renner 2012 found that paracervical block increased the median satisfaction with pain control and with the procedure (73 versus 49, P < 0.01; and 90 versus 84, P = 0.04 respectively).

Requirement of additional analgesia

There was no evidence that paracervical block affected this outcome (Renner 2012).

Paracervical local anaesthesia versus other regional anaesthesia

(Analysis 3.1 to Analysis 3.3)

Five studies (Al‐Sunaidi 2007; Finikiotis 1992; Kan 2004; Mankowski 2009; Yazaci 2003) compared paracervical block to other local anaesthetic techniques: uterosacral block (Finikiotis 1992), intracervical block (Al‐Sunaidi 2007; Kan 2004; Mankowski 2009), and intrauterine topical analgesia (Yazaci 2003).

Pain during cervical dilatation (Analysis 3.1)

There was no evidence that paracervical block affected this outcome.

Pain during uterine intervention (Analysis 3.2)

Statistically, the studies were too heterogeneous to summate. There was no evidence that paracervical block reduced severe pain, moderate or severe pain during hysteroscopy (Finikiotis 1992) (RR 0.17, 95% CI 0.42 to 3.27; and RR 1.22, 95% CI 0.80 to 1.85 respectively), see Appendix 17. Yazaci 2003 reported that intrauterine instillation of local anaesthetic caused worse pain than paracervical block, SMD 9.49 (95% CI 4.20 to 14.78) (Appendix 18). There was no evidence that pain was different during suction termination under sedation with paracervical block versus intracervical block (Kan 2004), or during hysteroscopy (Al‐Sunaidi 2007) or uterine curettage (Mankowski 2009). Paracervical block slightly reduced pain during endometrial biopsy compared with intrauterine local anaesthetic installation, MD on a 100‐point scale of 6.9 (95% CI 2.5 to 11.3, P = 0.002) (Yazaci 2003), see Additional Table 3.

Open in table viewer
Table 3. Pain during uterine intervention: paracervical local anaesthesia versus other regional anaesthesia, single study analyses

Outcomes

Study

Participants

Statistical method

Effect estimate

Endometrial biopsy

Yazaci 2003

114

Mean Difference (IV, Random, 95%CI)

‐6.92 [‐11.27 to ‐2.57]

Uterine curettage

Mankowski 2009

132

Mean Difference (IV, Random, 95%CI)

0.60 [‐0.32 to 1.52]

Hysteroscopy

Al‐Sunaidi 2007

84

Mean Difference (IV, Random, 95%CI)

‐1.10 [‐1.21 to ‐0.99]

Postoperative pain at different times (Analysis 3.3)

The studies were statistically too heterogeneous to summate. Paracervical block reduced postoperative pain in two studies (MD 4.63, 95% CI 0.24 to 9.02 (Yazaci 2003); and MD 0.40, 95% CI 0.29 to 0.51 (Al‐Sunaidi 2007) at 10 minutes, MD 0.70, 95% CI 0.61 to 0.79 at 30 minutes, and MD 0.20, 95% CI 0.13 to 0.27 at 60 minutes postoperation) (see Appendix 19).

Adverse effects

Yazaci 2003 did not find any difference in the risk of a vasovagal reaction (Appendix 20).

Paracervical local anaesthesia versus systemic analgesia

(Analysis 4.1 to Analysis 4.3)

Six studies (Buppasiri 2005; Guida 2003; Lopez 2007; Mola 1996; Sharma 2009; Thongrong 2011) compared paracervical block with systemic analgesics and sedatives: mefenamic acid (Buppasiri 2005); fentanyl and midazolam (Guida 2003); paracervical block plus diclofenac and meperidine plus diclofenac (Lopez 2007); pethidine and diazepam (Mola 1996); drotaverine with mefenamic acid and diazepam with pentazocine (Sharma 2009); and intravenous morphine (Thongrong 2011). The studies included women undergoing: fractional curettage (Buppasiri 2005; Thongrong 2011); hysteroscopy (Guida 2003); manual vacuum aspiration (Lopez 2007); bi‐manual removal of retained placenta (Mola 1996); hysteroscopy with endometrial biopsy (Sharma 2009).

Pain during uterine intervention (Analysis 4.1)

The studies were statistically too heterogeneous to summate. There was no evidence that pain during uterine intervention differed with paracervical block compared to systemic analgesia (also see Appendix 21 and Appendix 22).

Postoperative pain (Analysis 4.2)

Statistically the studies were too heterogeneous to summate. There was no evidence that pain after uterine intervention differed with paracervical block compared with systemic analgesia (also see Appendix 23).

Adverse effects (Analysis 4.3)

There was no evidence that the rates of pallor, hypotension, dizziness, or nausea or vomiting differed with paracervical block compared with systemic analgesia.

Requirement for postoperative analgesia

There was no evidence that the rates or doses of postoperative analgesics differed with paracervical block versus systemic analgesia. Buppasiri 2005 reported that three patients in each group needed additional drugs (intravenous pethidine). Guida 2003 and Lopez 2007 reported no significant difference in postoperative analgesic requirement between paracervical block and systemic analgesia (Appendix 24).

Patient satisfaction

There was no evidence for a difference in this outcome (see Appendix 25, Appendix 26).

Paracervical local anaesthesia versus general anaesthesia

We found no studies for this comparison.

Subgroup analysis

We did not perform any subgroup analysis because of the small number of included studies, and no data were available on potential factors for subgroup analysis.

Sensitivity analysis

We did not do sensitivity analyses because few studies were included in the review.

Discussion

Summary of main results

Twenty‐six included studies involving 2790 women compared paracervical block and other anaesthetic and analgesic methods for women undergoing uterine interventions. There was little evidence to support the belief that paracervical block made any consistent difference to any outcome.

Overall completeness and applicability of evidence

We were unable to assess the comparative effects of paracervical local anaesthesia (PLA) versus general anaesthesia as we did not find any studies. There appeared to be sufficient studies and measurements to address the other objectives of this review. Ten included studies, with 984 women, compared paracervical block with placebo (Amirian 2009; Chanrachakul 2001; Chatfield 1970; Chudnoff 2010; Cicinelli 1998; Egziabher 2002; Glantz 2001; Lau 1999; Miller 1996; Titapant 2003). PLA was compared with no anaesthesia in six studies (776 women) (Carroll 2005; Gómez 2004; Kan 2004; Lazenby 2009; Renner 2012; Vercellini 1994), with other regional anaesthesia methods in five studies (450 women) (Al‐Sunaidi 2007; Finikiotis 1992; Mankowski 2009; Kan 2004; Yazaci 2003), and systemic analgesia in six studies (580 women) (Buppasiri 2005; Guida 2003; Lopez 2007; Mola 1996; Sharma 2009; Thongrong 2011). All 26 studies measured pain as an outcome. Ten studies (Buppasiri 2005; Cicinelli 1998; Egziabher 2002; Guida 2003; Kan 2004; Lau 1999; Miller 1996; Renner 2012; Thongrong 2011; Yazaci 2003) had information on adverse effects, three studies reported patient satisfaction (Guida 2003; Kan 2004; Renner 2012), and five studies reported on postoperative analgesic requirements (Amirian 2009; Gómez 2004; Kan 2004; Lazenby 2009; Renner 2012). The women included in this review underwent both obstetric (dilatation curettage, manual placenta removal, manual vacuum aspiration) and gynaecologic (hysteroscopy, fractional curettage, endometrial biopsy or ablation) interventions.

Quality of the evidence

Fourteen of the 26 included studies (Amirian 2009; Carroll 2005; Chanrachakul 2001; Chudnoff 2010; Cicinelli 1998; Glantz 2001; Gómez 2004; Kan 2004; Lau 1999; Lazenby 2009; Lopez 2007; Mankowski 2009; Mola 1996; Renner 2012) had adequate random allocation concealment but we could not perform sensitivity analyses to evaluate the robustness of the result. This was because we had more than one comparison and each comparison had a limited number of included studies. Of the 26 included studies, 15 reported using some form of blinding. In conclusion, half of the included studies had adequate quality in terms of randomised allocation concealment and blinding.

Potential biases in the review process

We strictly followed the search strategies recommended by the Cochrane Anaesthesia Review Group (CARG). We searched all recommended databases and retrieved all the potential studies, except for three that remain unavailable in full text (Chaudhuri 1980; Regina 1987; Sen 1980). Since we used the recommended review process described in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011) any bias in the review should be minimal.

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
Figuras y tablas -
Figure 1

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
Figuras y tablas -
Figure 2

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

Searching results
Figuras y tablas -
Figure 3

Searching results

Comparison 1 Paracervical versus placebo, Outcome 1 Pain on speculum insertion.
Figuras y tablas -
Analysis 1.1

Comparison 1 Paracervical versus placebo, Outcome 1 Pain on speculum insertion.

Comparison 1 Paracervical versus placebo, Outcome 2 Pain on tenaculum placement.
Figuras y tablas -
Analysis 1.2

Comparison 1 Paracervical versus placebo, Outcome 2 Pain on tenaculum placement.

Comparison 1 Paracervical versus placebo, Outcome 3 Pain dilating cervix.
Figuras y tablas -
Analysis 1.3

Comparison 1 Paracervical versus placebo, Outcome 3 Pain dilating cervix.

Comparison 1 Paracervical versus placebo, Outcome 4 Pain during uterine interventions.
Figuras y tablas -
Analysis 1.4

Comparison 1 Paracervical versus placebo, Outcome 4 Pain during uterine interventions.

Comparison 1 Paracervical versus placebo, Outcome 5 Risk of any pain during uterine interventions.
Figuras y tablas -
Analysis 1.5

Comparison 1 Paracervical versus placebo, Outcome 5 Risk of any pain during uterine interventions.

Comparison 1 Paracervical versus placebo, Outcome 6 Risk of severe pain during uterine intervention.
Figuras y tablas -
Analysis 1.6

Comparison 1 Paracervical versus placebo, Outcome 6 Risk of severe pain during uterine intervention.

Comparison 1 Paracervical versus placebo, Outcome 7 Postoperative pain.
Figuras y tablas -
Analysis 1.7

Comparison 1 Paracervical versus placebo, Outcome 7 Postoperative pain.

Comparison 1 Paracervical versus placebo, Outcome 8 Shoulder pain.
Figuras y tablas -
Analysis 1.8

Comparison 1 Paracervical versus placebo, Outcome 8 Shoulder pain.

Comparison 1 Paracervical versus placebo, Outcome 9 Adverse effects.
Figuras y tablas -
Analysis 1.9

Comparison 1 Paracervical versus placebo, Outcome 9 Adverse effects.

Comparison 2 Paracervical versus no anaesthesia, Outcome 1 Postoperative pain at different times.
Figuras y tablas -
Analysis 2.1

Comparison 2 Paracervical versus no anaesthesia, Outcome 1 Postoperative pain at different times.

Comparison 3 Paracervical block versus other regional anaesthesia, Outcome 1 Pain during cervical dilatation.
Figuras y tablas -
Analysis 3.1

Comparison 3 Paracervical block versus other regional anaesthesia, Outcome 1 Pain during cervical dilatation.

Comparison 3 Paracervical block versus other regional anaesthesia, Outcome 2 Pain during uterine intervention: continuous.
Figuras y tablas -
Analysis 3.2

Comparison 3 Paracervical block versus other regional anaesthesia, Outcome 2 Pain during uterine intervention: continuous.

Comparison 3 Paracervical block versus other regional anaesthesia, Outcome 3 Postoperative pain at different time: continuous.
Figuras y tablas -
Analysis 3.3

Comparison 3 Paracervical block versus other regional anaesthesia, Outcome 3 Postoperative pain at different time: continuous.

Comparison 4 Paracervical versus systemic analgesia, Outcome 1 Pain during uterine intervention.
Figuras y tablas -
Analysis 4.1

Comparison 4 Paracervical versus systemic analgesia, Outcome 1 Pain during uterine intervention.

Comparison 4 Paracervical versus systemic analgesia, Outcome 2 Postoperative pain.
Figuras y tablas -
Analysis 4.2

Comparison 4 Paracervical versus systemic analgesia, Outcome 2 Postoperative pain.

Comparison 4 Paracervical versus systemic analgesia, Outcome 3 Adverse effects.
Figuras y tablas -
Analysis 4.3

Comparison 4 Paracervical versus systemic analgesia, Outcome 3 Adverse effects.

Summary of findings for the main comparison. Paracervical versus placebo for cervical dilatation and uterine intervention

Paracervical versus placebo for cervical dilation and uterine intervention

Patient or population: patients with cervical dilatation and uterine intervention
Settings:
Intervention: paracervical versus placebo

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of Participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Control

Paracervical versus placebo

Pain dilating cervix

The mean pain dilating cervix in the intervention groups was
0.37 standard deviations lower
(0.58 to 0.17 lower)

381
(4 studies)

⊕⊕⊕⊕
high

SMD ‐0.37 (‐0.58 to ‐0.17)

Pain during uterine intervention ‐ Risk of any pain

Study population

RR 0.85
(0.54 to 1.34)

242
(2 studies)

⊕⊕⊝⊝
low1

926 per 1000

787 per 1000
(500 to 1000)

Moderate

910 per 1000

773 per 1000
(491 to 1000)

Pain during uterine intervention ‐ Risk of severe pain

Study population

RR 0.16
(0.04 to 0.74)

242
(2 studies)

⊕⊕⊕⊝
moderate2

149 per 1000

24 per 1000
(6 to 110)

Moderate

156 per 1000

25 per 1000
(6 to 115)

Postoperative pain ‐ Immediately after the procedure

The mean postoperative pain ‐ immediately after the procedure in the intervention groups was
0.34 standard deviations lower
(0.92 lower to 0.24 higher)

223
(3 studies)

⊕⊕⊝⊝
low

SMD ‐0.34 (‐0.92 to 0.24)

Adverse effects ‐ Nausea and vomiting

Study population

RR 0.24
(0.02 to 2.8)

429
(3 studies)

⊕⊕⊕⊝
moderate

265 per 1000

64 per 1000
(5 to 742)

Moderate

250 per 1000

60 per 1000
(5 to 700)

Adverse effects ‐ Sweating

Study population

RR 1.08
(0.7 to 1.67)

142
(1 study)

⊕⊕⊕⊝
moderate

352 per 1000

380 per 1000
(246 to 588)

Moderate

352 per 1000

380 per 1000
(246 to 588)

Adverse effects ‐ Hypotension

Study population

RR 3.06
(1.21 to 7.78)

171
(2 studies)

⊕⊕⊕⊝
moderate

58 per 1000

178 per 1000
(70 to 452)

Moderate

50 per 1000

153 per 1000
(61 to 389)

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 Heterogeneity between studies may arise from differences in outcomes
2 Limitation of design: lack of allocation concealment

Figuras y tablas -
Summary of findings for the main comparison. Paracervical versus placebo for cervical dilatation and uterine intervention
Summary of findings 2. Paracervical versus no anaesthesia for cervical dilatation and uterine intervention

Paracervical versus no anaesthesia for cervical dilatation and uterine intervention

Patient or population: patients with cervical dilatation and uterine intervention
Settings:
Intervention: paracervical versus no anaesthesia

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of Participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Control

Paracervical versus no anaesthesia

Pain during the procedure

Study population

OR 0.99
(0.52 to 1.86)

215
(1 study)

⊕⊕⊕⊕
high

769 per 1000

767 per 1000
(633 to 861)

Moderate

769 per 1000

767 per 1000
(634 to 861)

Postoperative pain at different times ‐ Immediately after the procedure

The mean postoperative pain at different times ‐ immediately after the procedure in the intervention groups was
0.46 lower
(1.22 lower to 0.3 higher)

273
(2 studies)

⊕⊕⊕⊕
high

Postoperative pain at different times ‐ 5 minutes after the procedure

The mean postoperative pain at different times ‐ 5 minutes after the procedure in the intervention groups was
0.46 lower
(1.41 lower to 0.49 higher)

58
(1)

See comment

Postoperative pain at different times ‐ 10 minutes after the procedure

The mean postoperative pain at different times ‐ 10 minutes after the procedure in the intervention groups was
0.04 lower
(0.69 lower to 0.61 higher)

58
(1 study)

See comment

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; OR: Odds ratio

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

Figuras y tablas -
Summary of findings 2. Paracervical versus no anaesthesia for cervical dilatation and uterine intervention
Summary of findings 3. Paracervical block versus other regional anaesthesia for cervical dilatation and uterine intervention

Paracervical block versus other regional anaesthesia for cervical dilatation and uterine intervention

Patient or population: patients with cervical dilatation and uterine intervention
Settings:
Intervention: paracervical block versus other regional anaesthesia

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of Participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Control

Paracervical block versus other regional anaesthesia

Pain during the procedure

Study population

OR 1.41
(0.68 to 2.91)

120
(1 study)

⊕⊕⊕⊝
moderate1

383 per 1000

467 per 1000
(297 to 644)

Moderate

383 per 1000

467 per 1000
(297 to 644)

Pain during cervical dilatation

The mean pain during cervical dilatation in the intervention groups was
0.52 lower
(1.28 lower to 0.24 higher)

163
(2 studies)

⊕⊕⊝⊝
low2

Pain during uterine intervention: continuous

See comment

See comment

Not estimable

271
(3 studies)

⊕⊝⊝⊝
very low3,4

Postoperative pain at different time: continuous

See comment

See comment

Not estimable

307
(2 studies)

⊕⊕⊕⊕
high

Adverse effects

See comment

See comment

Not estimable

55
(1 study)

⊕⊕⊝⊝
low5

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; OR: Odds ratio

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 Limitation of study: lack of allocation concealment, blinding
2 Heterogeneity between studies may arise from differences of populations
3 Heterogeneity between studies may arise from difference of outcomes
4 Imprecision: the study had wide confidence intervals around the estimate of the effect
5 Limitation of study: lack of blinding

Figuras y tablas -
Summary of findings 3. Paracervical block versus other regional anaesthesia for cervical dilatation and uterine intervention
Summary of findings 4. Paracervical versus systemic analgesia for cervical dilatation and uterine intervention

Paracervical versus systemic analgesia for cervical dilatation and uterine intervention

Patient or population: patients with cervical dilatation and uterine intervention
Settings:
Intervention: paracervical versus systemic analgesia

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of Participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Control

Paracervical versus systemic analgesia

Pain during uterine intervention

See comment

See comment

Not estimable

402
(3 studies)

⊕⊕⊝⊝
low1

Postoperative pain

See comment

See comment

Not estimable

984
(2 studies)

⊕⊕⊕⊕
high

Requirement for postoperative analgesics

See comment

See comment

Not estimable

166
(1 study)

⊕⊕⊝⊝
low

Adverse effects

See comment

See comment

Not estimable

571
(3 studies)

⊕⊕⊝⊝
low

Patient satisfaction

Study population

Not estimable

166
(1 study)

⊕⊕⊝⊝
low

940 per 1000

0 per 1000
(0 to 0)

Moderate

941 per 1000

0 per 1000
(0 to 0)

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 Limitation of studies: lack of allocation concealment, blinding

Figuras y tablas -
Summary of findings 4. Paracervical versus systemic analgesia for cervical dilatation and uterine intervention
Table 1. Pain: paracervical local anaesthesia versus placebo, single study analyses

Outcome

Study

Participants

Statistical method

Effect estimate

Pain on intracervical injection

Chudnoff 2010

80

Mean Difference (IV, Fixed, 95%CI)

‐0.63 [‐1.33 to 0.07]

Figuras y tablas -
Table 1. Pain: paracervical local anaesthesia versus placebo, single study analyses
Table 2. Pain during uterine intervention: paracervical local anaesthesia versus no anaesthesia, single study analyses

Outcomes

Study

Participants

Statistical method

Effect estimate

Hysteroscopy

Vercellini 1994

177

Mean Difference (IV, Random, 95%CI)

‐0.40 [‐1.02 to 0.22]

Endometrial biopsy

Vercellini 1994

177

Mean Difference (IV, Random, 95%CI)

‐0.50 [‐1.16 to 0.16]

Aspiration

Renner 2012

120

Mean Difference (IV, Fixed, 95% CI)

‐26.00 [‐33.48, ‐18.52]

Figuras y tablas -
Table 2. Pain during uterine intervention: paracervical local anaesthesia versus no anaesthesia, single study analyses
Table 3. Pain during uterine intervention: paracervical local anaesthesia versus other regional anaesthesia, single study analyses

Outcomes

Study

Participants

Statistical method

Effect estimate

Endometrial biopsy

Yazaci 2003

114

Mean Difference (IV, Random, 95%CI)

‐6.92 [‐11.27 to ‐2.57]

Uterine curettage

Mankowski 2009

132

Mean Difference (IV, Random, 95%CI)

0.60 [‐0.32 to 1.52]

Hysteroscopy

Al‐Sunaidi 2007

84

Mean Difference (IV, Random, 95%CI)

‐1.10 [‐1.21 to ‐0.99]

Figuras y tablas -
Table 3. Pain during uterine intervention: paracervical local anaesthesia versus other regional anaesthesia, single study analyses
Comparison 1. Paracervical versus placebo

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Pain on speculum insertion Show forest plot

2

202

Std. Mean Difference (IV, Random, 95% CI)

0.20 [‐0.35, 0.74]

2 Pain on tenaculum placement Show forest plot

3

249

Mean Difference (IV, Random, 95% CI)

‐0.70 [‐2.26, 0.86]

3 Pain dilating cervix Show forest plot

4

381

Mean Difference (IV, Random, 95% CI)

‐0.96 [‐1.91, ‐0.01]

4 Pain during uterine interventions Show forest plot

6

696

Std. Mean Difference (IV, Random, 95% CI)

‐0.74 [‐1.19, ‐0.28]

4.1 Pain when the uterus is distended by carbon dioxide

1

99

Std. Mean Difference (IV, Random, 95% CI)

0.0 [‐0.39, 0.39]

4.2 hysteroscopy

1

72

Std. Mean Difference (IV, Random, 95% CI)

‐1.71 [‐2.26, ‐1.17]

4.3 Endometrial biopsy

2

171

Std. Mean Difference (IV, Random, 95% CI)

‐0.85 [‐2.44, 0.74]

4.4 Uterine curettage

2

220

Std. Mean Difference (IV, Random, 95% CI)

‐0.90 [‐1.47, ‐0.32]

4.5 Suction evacuation or aspiration

2

134

Std. Mean Difference (IV, Random, 95% CI)

‐0.38 [‐1.02, 0.25]

5 Risk of any pain during uterine interventions Show forest plot

2

242

Risk Ratio (M‐H, Random, 95% CI)

0.87 [0.68, 1.12]

6 Risk of severe pain during uterine intervention Show forest plot

2

242

Risk Ratio (M‐H, Random, 95% CI)

0.16 [0.04, 0.74]

7 Postoperative pain Show forest plot

6

Std. Mean Difference (IV, Random, 95% CI)

Subtotals only

7.1 Immediately after the procedure

3

223

Std. Mean Difference (IV, Random, 95% CI)

‐0.34 [‐0.92, 0.24]

7.2 5 min after the procedure

1

80

Std. Mean Difference (IV, Random, 95% CI)

0.09 [‐0.35, 0.53]

7.3 15 minutes after the procedure

1

72

Std. Mean Difference (IV, Random, 95% CI)

‐0.94 [‐1.43, ‐0.45]

7.4 30 minutes after the procedure

4

371

Std. Mean Difference (IV, Random, 95% CI)

‐0.04 [‐0.26, 0.18]

8 Shoulder pain Show forest plot

2

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

8.1 During the procedure

2

144

Risk Ratio (M‐H, Fixed, 95% CI)

0.5 [0.05, 5.39]

8.2 After the procedure

2

241

Risk Ratio (M‐H, Fixed, 95% CI)

1.33 [0.51, 3.49]

9 Adverse effects Show forest plot

4

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

9.1 Nausea/vomiting

3

429

Risk Ratio (M‐H, Random, 95% CI)

0.24 [0.02, 2.80]

9.2 Sweating

1

142

Risk Ratio (M‐H, Random, 95% CI)

1.08 [0.70, 1.67]

9.3 Hypotension

2

171

Risk Ratio (M‐H, Random, 95% CI)

3.06 [1.21, 7.78]

Figuras y tablas -
Comparison 1. Paracervical versus placebo
Comparison 2. Paracervical versus no anaesthesia

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Postoperative pain at different times Show forest plot

2

Std. Mean Difference (IV, Fixed, 95% CI)

Subtotals only

1.1 Immediately after the procedure

2

128

Std. Mean Difference (IV, Fixed, 95% CI)

‐0.37 [‐0.72, ‐0.02]

1.2 5 minutes after the procedure

1

58

Std. Mean Difference (IV, Fixed, 95% CI)

‐0.25 [‐0.77, 0.27]

1.3 10 minutes after the procedure

1

58

Std. Mean Difference (IV, Fixed, 95% CI)

‐0.03 [‐0.55, 0.48]

Figuras y tablas -
Comparison 2. Paracervical versus no anaesthesia
Comparison 3. Paracervical block versus other regional anaesthesia

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Pain during cervical dilatation Show forest plot

2

163

Std. Mean Difference (IV, Random, 95% CI)

‐1.04 [‐2.99, 0.91]

2 Pain during uterine intervention: continuous Show forest plot

3

271

Mean Difference (IV, Random, 95% CI)

‐0.55 [‐1.24, 0.13]

2.1 Endometrial biopsy

1

55

Mean Difference (IV, Random, 95% CI)

‐0.69 [‐1.13, ‐0.25]

2.2 Uterine curettage

1

132

Mean Difference (IV, Random, 95% CI)

0.60 [‐0.32, 1.52]

2.3 Hysteroscopy

1

84

Mean Difference (IV, Random, 95% CI)

‐1.1 [‐1.21, ‐0.99]

3 Postoperative pain at different time: continuous Show forest plot

2

307

Mean Difference (IV, Fixed, 95% CI)

‐0.39 [‐0.44, ‐0.35]

3.1 10 minutes after the procedure

1

84

Mean Difference (IV, Fixed, 95% CI)

‐0.40 [‐0.51, ‐0.29]

3.2 15 minutes after the procedure

1

55

Mean Difference (IV, Fixed, 95% CI)

‐0.46 [‐0.90, ‐0.02]

3.3 30 minutes after the procedure

1

84

Mean Difference (IV, Fixed, 95% CI)

‐0.7 [‐0.79, ‐0.61]

3.4 60 minutes after the procedure

1

84

Mean Difference (IV, Fixed, 95% CI)

‐0.20 [‐0.27, ‐0.13]

Figuras y tablas -
Comparison 3. Paracervical block versus other regional anaesthesia
Comparison 4. Paracervical versus systemic analgesia

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Pain during uterine intervention Show forest plot

3

362

Mean Difference (IV, Fixed, 95% CI)

0.36 [0.16, 0.57]

1.1 hysteroscopic electrosurgery

1

166

Mean Difference (IV, Fixed, 95% CI)

0.20 [‐0.03, 0.43]

1.2 manual vacuum aspiration

1

76

Mean Difference (IV, Fixed, 95% CI)

0.40 [‐0.82, 1.62]

1.3 Hysteroscopy and endometrial biopsy:1

1

60

Mean Difference (IV, Fixed, 95% CI)

1.80 [1.12, 2.48]

1.4 Hysteroscopy and endometrial biopsy:2

1

60

Mean Difference (IV, Fixed, 95% CI)

0.35 [‐0.37, 1.07]

2 Postoperative pain Show forest plot

2

904

Mean Difference (IV, Fixed, 95% CI)

‐0.00 [‐0.03, 0.03]

2.1 at 15 minutes

1

166

Mean Difference (IV, Fixed, 95% CI)

0.10 [‐0.19, 0.39]

2.2 at 30 minutes

1

120

Mean Difference (IV, Fixed, 95% CI)

0.53 [0.21, 0.85]

2.3 at 1 hour

2

286

Mean Difference (IV, Fixed, 95% CI)

0.42 [0.23, 0.62]

2.4 at 24 hours

1

166

Mean Difference (IV, Fixed, 95% CI)

‐0.20 [‐0.31, ‐0.09]

2.5 at 3 days

1

166

Mean Difference (IV, Fixed, 95% CI)

0.0 [‐0.03, 0.03]

3 Adverse effects Show forest plot

3

571

Risk Ratio (M‐H, Random, 95% CI)

0.51 [0.21, 1.20]

3.1 Pallor or hypotension

1

166

Risk Ratio (M‐H, Random, 95% CI)

0.82 [0.23, 2.94]

3.2 Nausea and vomiting

2

242

Risk Ratio (M‐H, Random, 95% CI)

0.38 [0.10, 1.50]

3.3 Dizziness

2

163

Risk Ratio (M‐H, Random, 95% CI)

1.01 [0.04, 25.55]

Figuras y tablas -
Comparison 4. Paracervical versus systemic analgesia